A STING pathway-activatable contrast agent for MRI-guided tumor immunoferroptosis synergistic therapy.
Guo S, Xiong W, Zhu J, Feng J, Zhou R, Fan Q, Zhang Q, Li Z, Yang J, Zhou H, Yi P, Feng Y, Yang S, Qiu X, Xu Y, Shen Z.
Guo S, et al. Among authors: yi p.
Biomaterials. 2023 Nov;302:122300. doi: 10.1016/j.biomaterials.2023.122300. Epub 2023 Aug 29.
Biomaterials. 2023.
PMID: 37659110